Dr. Patrick Walsh's Guide to Surviving Prostate Cancer, Second Edition
Dr. Patrick Walsh's Guide to Surviving Prostate Cancer, Second Edition
by Patrick C. Walsh Janet Farrar Worthington
Our Price: $10.19
Used from: $2.59

The Definitive Guide to Prostate Cancer: Everything You Need to Know about Conventional and Integrative Therapies
The Definitive Guide to Prostate Cancer: Everything You Need to Know about Conventional and Integrative Therapies
by Dr. Aaron Katz
Our Price: $10.19
Used from: $9.16

The Decision: Your prostate biopsy shows cancer. Now what?: Medical insight, personal stories, and humor by a urologist who has been where you are now.
The Decision: Your prostate biopsy shows cancer. Now what?: Medical insight, personal stories, and humor by a urologist who has been where you are now.
by John C. McHugh M.D.
Our Price: $13.24
Used from: $12.14

Winning the Battle Against Prostate Cancer: Get the Treatment That is Right for You
Winning the Battle Against Prostate Cancer: Get the Treatment That is Right for You
by Gerald Chodak
Our Price: $11.37
Used from: $9.48

Prostate and Cancer: A Family Guide to Diagnosis, Treatment, and Survival
Prostate and Cancer: A Family Guide to Diagnosis, Treatment, and Survival
by Sheldon Marks MD
Our Price: $12.21
Used from: $3.99



Prostate Cancer Survivor Links


<< 1 2 3 >>




Prostate Cancer Survivor News


Third Peer-Reviewed Study Proves Botanical Formula Fights Prostate Cancer ... - MarketWatch (press release)


Third Peer-Reviewed Study Proves Botanical Formula Fights Prostate Cancer ...
MarketWatch (press release)
8, 2012 /PRNewswire via COMTEX/ -- Scientists at Indiana University, Methodist Research Institute, study a botanical formula that kills aggressive prostate cancer tumors. Their findings, based on experiments in mice using a human prostate cancer tumor ...

and more »

Read more...


Benefit of Bone Drug in Prostate Cancer in Doubt - MedPage Today


USA TODAY

Benefit of Bone Drug in Prostate Cancer in Doubt
MedPage Today
"Though the study met the prespecified primary endpoint, with a statistically significant prolongation in [bone metastases free survival], it is unclear whether an improvement [of] 4.2 months alone in patients with [castrate-resistant prostate cancer] ...
FDA questions Amgen drug for prostate cancerUSA TODAY
Can Amgen Convince Docs to Recommend Approval?DailyFinance
FDA Questions Benefit of Amgen Bone Drug in Certain CasesWall Street Journal (blog)
GlobalPost
all 222 news articles »

Read more...